LAB
Standard BioTools Inc. · Healthcare
Casdin Partners Master Fund, L.P. bought $1.7M of Standard BioTools Inc.
Director and 10% owner
Bought$1,718,801
$1.61Price
1,069,562Shares
+2%Stake
What LAB did for a copier
- $1,000 copied at Mon, Aug 12 open, $1.67
- $1,180
- S&P 500, same days
- +7.3%
Measured over 30 trading days, to the Sep 24 close.
Casdin Partners Master Fund, L.P.'s record
18 other buys with 3 months of prices since 2020: on average −10.8% against the S&P 500, and 6 of 18 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Aug 7. Filed Fri, Aug 9, 5:34 PM ET, after the close. Returns use the Aug 12 open and the Sep 24 close. Not investment advice.